tm logo
ABILIFY
Live/Registered
REGISTERED AND RENEWED

on 06 Feb 2024

Last Applicant/ Owned by

2-9, KANDA-TSUKASAMACHI, CHIYODA-KU

TOKYO

JP

101-8535

Serial Number

78135340 filed on 13th Jun 2002

Registration Number

2772697 registered on 07th Oct 2003

in the Principal Register

Correspondent Address

Scott S. Havlick

Scott S. Havlick

P.O. Box 8749

Attn: Trademark Docketing

Denver, CO 80201

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ABILIFY

Pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, ] central nervous system diseases [ and disorders ] [, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, antibiotics ]

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, ] central nervous system diseases [ and disorders ] [, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, antibiotics ]


First Use Date in General

19th Nov 2002

First Use Date in Commerce

19th Nov 2002

Mark Details


Serial Number

No 78135340

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 57182.0313

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Feb 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Feb 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06th Feb 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06th Feb 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10th Aug 2023TEAS SECTION 8 & 9 RECEIVED
07th Oct 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02th Aug 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Aug 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02th Aug 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02th Aug 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED